Can MGUS be linked to kidney problems?

 

In this video, Dr. Brian Durie explains that even when a patient has MGUS, which is typically a benign stage in myeloma, problems can emerge.

BOTTOM LINE:
MGUS patients may benefit from treatment if the monoclonal protein has caused damage.

Have a question? Submit it to AskDrDurie@myeloma.org

IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to askdrdurie@myeloma.org!

For questions of a specific personal nature, please call the IMF InfoLine coordinators at 800.452.2873 or email them at infoline@myeloma.org